In breast cancer alone, up to 50% of patients with Rbness in the absence of RB1 genomic alterations harbored amplifications in PIK3CA, RB (CCND1 and CCNE1), and ER signaling modules (ESR1, FOXA1, and GATA3). This evidence concerns the gene FOXA1 and breast carcinoma.